APO Research
Talk to an analyst

APO RESEARCH · REPORT

Head Lice Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Head Lice Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchHead Lice Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Head Lice Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Head Lice Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Head Lice Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Head Lice Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Head Lice Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Head Lice Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Head Lice Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Head Lice Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Head Lice Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Head Lice Drug include Bayer, Tianren, TecLabs, Stada Arzneimittel, Reckitt Benckier, Prestige Brands, Perrigo, Pediapharm and ParaPRO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Head Lice Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Head Lice Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Head Lice Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Head Lice Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Head Lice Drug Segment by Company

Bayer

Tianren

TecLabs

Stada Arzneimittel

Reckitt Benckier

Prestige Brands

Perrigo

Pediapharm

ParaPRO

Nuvo Pharmaceuticals

Logic Products

Cerecor Inc.

Arborpharma

Alliance Pharma Inc.

Head Lice Drug Segment by Type

Shampoo

Lotion

Creams

Other

Head Lice Drug Segment by Application

Children

Adult

Head Lice Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Head Lice Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Head Lice Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Head Lice Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Head Lice Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Head Lice Drug industry.

Chapter 3: Detailed analysis of Head Lice Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Head Lice Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Head Lice Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Shampoo Table 3. Key Players of Lotion Table 4. Key Players of Creams Table 3. Key Players of Other Table 4. Global Head Lice Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Children Table 6. Key Players of Adult Table 7. Global Head Lice Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Head Lice Drug Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Head Lice Drug Market Share by Region (2021-2026) Table 10. Global Head Lice Drug Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Head Lice Drug Market Share by Region (2027-2032) Table 12. Head Lice Drug Industry Trends Table 13. Head Lice Drug Industry Drivers Table 14. Head Lice Drug Industry Opportunities and Challenges Table 15. Head Lice Drug Industry Restraints Table 16. Global Head Lice Drug Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Head Lice Drug Revenue Market Share by Company (2021-2026) Table 18. Global Head Lice Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Head Lice Drug Key Company Head Office and Area Served Table 20. Global Head Lice Drug Company, Product Type & Application Table 21. Global Head Lice Drug Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Head Lice Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Head Lice Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Head Lice Drug Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Head Lice Drug Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Head Lice Drug Revenue Market Share by Type (2021-2026) Table 28. Global Head Lice Drug Revenue Market Share by Type (2027-2032) Table 29. Global Head Lice Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Head Lice Drug Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Head Lice Drug Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Head Lice Drug Revenue Market Share by Application (2021-2026) Table 33. Global Head Lice Drug Revenue Market Share by Application (2027-2032) Table 34. Bayer Company Information Table 35. Bayer Business Overview Table 36. Bayer Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Bayer Head Lice Drug Product Portfolio Table 38. Bayer Recent Development Table 39. Tianren Company Information Table 40. Tianren Business Overview Table 41. Tianren Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Tianren Head Lice Drug Product Portfolio Table 43. Tianren Recent Development Table 44. TecLabs Company Information Table 45. TecLabs Business Overview Table 46. TecLabs Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. TecLabs Head Lice Drug Product Portfolio Table 48. TecLabs Recent Development Table 49. Stada Arzneimittel Company Information Table 50. Stada Arzneimittel Business Overview Table 51. Stada Arzneimittel Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Stada Arzneimittel Head Lice Drug Product Portfolio Table 53. Stada Arzneimittel Recent Development Table 54. Reckitt Benckier Company Information Table 55. Reckitt Benckier Business Overview Table 56. Reckitt Benckier Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Reckitt Benckier Head Lice Drug Product Portfolio Table 58. Reckitt Benckier Recent Development Table 59. Prestige Brands Company Information Table 60. Prestige Brands Business Overview Table 61. Prestige Brands Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Prestige Brands Head Lice Drug Product Portfolio Table 63. Prestige Brands Recent Development Table 64. Perrigo Company Information Table 65. Perrigo Business Overview Table 66. Perrigo Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Perrigo Head Lice Drug Product Portfolio Table 68. Perrigo Recent Development Table 69. Pediapharm Company Information Table 70. Pediapharm Business Overview Table 71. Pediapharm Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Pediapharm Head Lice Drug Product Portfolio Table 73. Pediapharm Recent Development Table 74. ParaPRO Company Information Table 75. ParaPRO Business Overview Table 76. ParaPRO Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. ParaPRO Head Lice Drug Product Portfolio Table 78. ParaPRO Recent Development Table 79. Nuvo Pharmaceuticals Company Information Table 80. Nuvo Pharmaceuticals Business Overview Table 81. Nuvo Pharmaceuticals Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Nuvo Pharmaceuticals Head Lice Drug Product Portfolio Table 83. Nuvo Pharmaceuticals Recent Development Table 84. Logic Products Company Information Table 85. Logic Products Business Overview Table 86. Logic Products Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Logic Products Head Lice Drug Product Portfolio Table 88. Logic Products Recent Development Table 89. Cerecor Inc. Company Information Table 90. Cerecor Inc. Business Overview Table 91. Cerecor Inc. Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Cerecor Inc. Head Lice Drug Product Portfolio Table 93. Cerecor Inc. Recent Development Table 94. Arborpharma Company Information Table 95. Arborpharma Business Overview Table 96. Arborpharma Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Arborpharma Head Lice Drug Product Portfolio Table 98. Arborpharma Recent Development Table 99. Alliance Pharma Inc. Company Information Table 100. Alliance Pharma Inc. Business Overview Table 101. Alliance Pharma Inc. Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Alliance Pharma Inc. Head Lice Drug Product Portfolio Table 103. Alliance Pharma Inc. Recent Development Table 104. North America Head Lice Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. North America Head Lice Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. North America Head Lice Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. North America Head Lice Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. North America Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Head Lice Drug Market Size by Country (2021-2026) Table 110. North America Head Lice Drug Market Size by Country (2027-2032) Table 111. Europe Head Lice Drug Market Size by Type (2021-2026) & (US$ Million) Table 112. Europe Head Lice Drug Market Size by Type (2027-2032) & (US$ Million) Table 113. Europe Head Lice Drug Market Size by Application (2021-2026) & (US$ Million) Table 114. Europe Head Lice Drug Market Size by Application (2027-2032) & (US$ Million) Table 115. Europe Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Head Lice Drug Market Size by Country (2021-2026) Table 117. Europe Head Lice Drug Market Size by Country (2027-2032) Table 118. China Head Lice Drug Market Size by Type (2021-2026) & (US$ Million) Table 119. China Head Lice Drug Market Size by Type (2027-2032) & (US$ Million) Table 120. China Head Lice Drug Market Size by Application (2021-2026) & (US$ Million) Table 121. China Head Lice Drug Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Head Lice Drug Market Size by Type (2021-2026) & (US$ Million) Table 123. Asia Head Lice Drug Market Size by Type (2027-2032) & (US$ Million) Table 124. Asia Head Lice Drug Market Size by Application (2021-2026) & (US$ Million) Table 125. Asia Head Lice Drug Market Size by Application (2027-2032) & (US$ Million) Table 126. Asia Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Head Lice Drug Market Size by Country (2021-2026) Table 128. Asia Head Lice Drug Market Size by Country (2027-2032) Table 129. South America, Middle East & Africa Head Lice Drug Market Size by Type (2021-2026) & (US$ Million) Table 130. South America, Middle East & Africa Head Lice Drug Market Size by Type (2027-2032) & (US$ Million) Table 131. South America, Middle East & Africa Head Lice Drug Market Size by Application (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa Head Lice Drug Market Size by Application (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. South America, Middle East & Africa Head Lice Drug Market Size by Country (2021-2026) Table 135. South America, Middle East & Africa Head Lice Drug Market Size by Country (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Head Lice Drug Product Image Figure 2. Global Head Lice Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Head Lice Drug Market Share by Type: 2025 VS 2032 Figure 4. Shampoo Image Figure 5. Lotion Image Figure 6. Creams Image Figure 7. Other Image Figure 8. Global Head Lice Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Head Lice Drug Market Share by Application: 2025 VS 2032 Figure 10. Children Image Figure 11. Adult Image Figure 12. Global Head Lice Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Head Lice Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Head Lice Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Head Lice Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Head Lice Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Head Lice Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Head Lice Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Head Lice Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Head Lice Drug Market Share by Type (2021-2032) Figure 25. North America Head Lice Drug Market Share by Application (2021-2032) Figure 26. North America Head Lice Drug Market Share by Country (2021-2032) Figure 27. United States Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Head Lice Drug Market Share by Type (2021-2032) Figure 32. Europe Head Lice Drug Market Share by Application (2021-2032) Figure 33. Europe Head Lice Drug Market Share by Country (2021-2032) Figure 34. Germany Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Head Lice Drug Market Share by Type (2021-2032) Figure 42. China Head Lice Drug Market Share by Application (2021-2032) Figure 43. Asia Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Head Lice Drug Market Share by Type (2021-2032) Figure 45. Asia Head Lice Drug Market Share by Application (2021-2032) Figure 46. Asia Head Lice Drug Market Share by Country (2021-2032) Figure 47. Japan Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Head Lice Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Head Lice Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Head Lice Drug Market Share by Country (2021-2032) Figure 57. Brazil Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Head Lice Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Shampoo
  • Lotion
  • Creams
  • Other
Applications
  • Children
  • Adult
Companies covered
  • Bayer
  • Tianren
  • TecLabs
  • Stada Arzneimittel
  • Reckitt Benckier
  • Prestige Brands
  • Perrigo
  • Pediapharm
  • ParaPRO
  • Nuvo Pharmaceuticals
  • Logic Products
  • Cerecor Inc.
  • Arborpharma
  • Alliance Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Head Lice Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Shampoo
  5. 1.2.3 Lotion
  6. 1.2.4 Creams
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Head Lice Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Children
  11. 1.3.3 Adult
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Head Lice Drug Growth Trends by Region
  14. 1.5.1 Global Head Lice Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Head Lice Drug Market Size by Region (2021-2026)
  16. 1.5.3 Head Lice Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Head Lice Drug Market Dynamics
  1. 2.1 Head Lice Drug Industry Trends
  2. 2.2 Head Lice Drug Industry Drivers
  3. 2.3 Head Lice Drug Industry Opportunities and Challenges
  4. 2.4 Head Lice Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Head Lice Drug Revenue by Company (2021-2026)
  2. 3.2 Global Head Lice Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Head Lice Drug Key Company Head office and Area Served
  4. 3.4 Global Head Lice Drug Company, Product Type & Application
  5. 3.5 Global Head Lice Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Head Lice Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Head Lice Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Head Lice Drug Tier 1, Tier 2, and Tier 3
4 Head Lice Drug Market by Type
  1. 4.1 Global Head Lice Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Head Lice Drug Market Size by Type (2021-2032)
  3. 4.3 Global Head Lice Drug Market Size Share by Type (2021-2032)
5 Head Lice Drug Market by Application
  1. 5.1 Global Head Lice Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Head Lice Drug Market Size by Application (2021-2032)
  3. 5.3 Global Head Lice Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bayer
  2. 6.1.1 Bayer Company Information
  3. 6.1.2 Bayer Business Overview
  4. 6.1.3 Bayer Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bayer Head Lice Drug Product Portfolio
  6. 6.1.5 Bayer Recent Developments
  7. 6.2 Tianren
  8. 6.2.1 Tianren Company Information
  9. 6.2.2 Tianren Business Overview
  10. 6.2.3 Tianren Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Tianren Head Lice Drug Product Portfolio
  12. 6.2.5 Tianren Recent Developments
  13. 6.3 TecLabs
  14. 6.3.1 TecLabs Company Information
  15. 6.3.2 TecLabs Business Overview
  16. 6.3.3 TecLabs Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 TecLabs Head Lice Drug Product Portfolio
  18. 6.3.5 TecLabs Recent Developments
  19. 6.4 Stada Arzneimittel
  20. 6.4.1 Stada Arzneimittel Company Information
  21. 6.4.2 Stada Arzneimittel Business Overview
  22. 6.4.3 Stada Arzneimittel Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Stada Arzneimittel Head Lice Drug Product Portfolio
  24. 6.4.5 Stada Arzneimittel Recent Developments
  25. 6.5 Reckitt Benckier
  26. 6.5.1 Reckitt Benckier Company Information
  27. 6.5.2 Reckitt Benckier Business Overview
  28. 6.5.3 Reckitt Benckier Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Reckitt Benckier Head Lice Drug Product Portfolio
  30. 6.5.5 Reckitt Benckier Recent Developments
  31. 6.6 Prestige Brands
  32. 6.6.1 Prestige Brands Company Information
  33. 6.6.2 Prestige Brands Business Overview
  34. 6.6.3 Prestige Brands Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Prestige Brands Head Lice Drug Product Portfolio
  36. 6.6.5 Prestige Brands Recent Developments
  37. 6.7 Perrigo
  38. 6.7.1 Perrigo Company Information
  39. 6.7.2 Perrigo Business Overview
  40. 6.7.3 Perrigo Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Perrigo Head Lice Drug Product Portfolio
  42. 6.7.5 Perrigo Recent Developments
  43. 6.8 Pediapharm
  44. 6.8.1 Pediapharm Company Information
  45. 6.8.2 Pediapharm Business Overview
  46. 6.8.3 Pediapharm Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pediapharm Head Lice Drug Product Portfolio
  48. 6.8.5 Pediapharm Recent Developments
  49. 6.9 ParaPRO
  50. 6.9.1 ParaPRO Company Information
  51. 6.9.2 ParaPRO Business Overview
  52. 6.9.3 ParaPRO Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ParaPRO Head Lice Drug Product Portfolio
  54. 6.9.5 ParaPRO Recent Developments
  55. 6.10 Nuvo Pharmaceuticals
  56. 6.10.1 Nuvo Pharmaceuticals Company Information
  57. 6.10.2 Nuvo Pharmaceuticals Business Overview
  58. 6.10.3 Nuvo Pharmaceuticals Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nuvo Pharmaceuticals Head Lice Drug Product Portfolio
  60. 6.10.5 Nuvo Pharmaceuticals Recent Developments
  61. 6.11 Logic Products
  62. 6.11.1 Logic Products Company Information
  63. 6.11.2 Logic Products Business Overview
  64. 6.11.3 Logic Products Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Logic Products Head Lice Drug Product Portfolio
  66. 6.11.5 Logic Products Recent Developments
  67. 6.12 Cerecor Inc.
  68. 6.12.1 Cerecor Inc. Company Information
  69. 6.12.2 Cerecor Inc. Business Overview
  70. 6.12.3 Cerecor Inc. Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Cerecor Inc. Head Lice Drug Product Portfolio
  72. 6.12.5 Cerecor Inc. Recent Developments
  73. 6.13 Arborpharma
  74. 6.13.1 Arborpharma Company Information
  75. 6.13.2 Arborpharma Business Overview
  76. 6.13.3 Arborpharma Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Arborpharma Head Lice Drug Product Portfolio
  78. 6.13.5 Arborpharma Recent Developments
  79. 6.14 Alliance Pharma Inc.
  80. 6.14.1 Alliance Pharma Inc. Company Information
  81. 6.14.2 Alliance Pharma Inc. Business Overview
  82. 6.14.3 Alliance Pharma Inc. Head Lice Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Alliance Pharma Inc. Head Lice Drug Product Portfolio
  84. 6.14.5 Alliance Pharma Inc. Recent Developments
7 North America
  1. 7.1 North America Head Lice Drug Market Size (2021-2032)
  2. 7.2 North America Head Lice Drug Market Size by Type
  3. 7.2.1 North America Head Lice Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Head Lice Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Head Lice Drug Market Share by Type (2021-2032)
  6. 7.3 North America Head Lice Drug Market Size by Application
  7. 7.3.1 North America Head Lice Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Head Lice Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Head Lice Drug Market Share by Application (2021-2032)
  10. 7.4 North America Head Lice Drug Market Size by Country
  11. 7.4.1 North America Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Head Lice Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Head Lice Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Head Lice Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Head Lice Drug Market Size (2021-2032)
  2. 8.2 Europe Head Lice Drug Market Size by Type
  3. 8.2.1 Europe Head Lice Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Head Lice Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Head Lice Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Head Lice Drug Market Size by Application
  7. 8.3.1 Europe Head Lice Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Head Lice Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Head Lice Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Head Lice Drug Market Size by Country
  11. 8.4.1 Europe Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Head Lice Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Head Lice Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Head Lice Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Head Lice Drug Market Size (2021-2032)
  2. 9.2 China Head Lice Drug Market Size by Type
  3. 9.2.1 China Head Lice Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Head Lice Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Head Lice Drug Market Share by Type (2021-2032)
  6. 9.3 China Head Lice Drug Market Size by Application
  7. 9.3.1 China Head Lice Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Head Lice Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Head Lice Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Head Lice Drug Market Size (2021-2032)
  2. 10.2 Asia Head Lice Drug Market Size by Type
  3. 10.2.1 Asia Head Lice Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Head Lice Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Head Lice Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Head Lice Drug Market Size by Application
  7. 10.3.1 Asia Head Lice Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Head Lice Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Head Lice Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Head Lice Drug Market Size by Country
  11. 10.4.1 Asia Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Head Lice Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Head Lice Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Head Lice Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Head Lice Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Head Lice Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Head Lice Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Head Lice Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Head Lice Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Head Lice Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Head Lice Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Head Lice Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Head Lice Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Head Lice Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Head Lice Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Head Lice Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Head Lice Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Head Lice Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst